NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









DecisionRx

DecisionRx

Private
Dover, DelawareHealthcare & Life Scienceshttps://decisionrx.com/

Last Round

Debt

Jan 11, 2024

Total Funding Raised

$110M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

DecisionRx is a managed care company that has developed a medication management platform designed to manage risk, make safer prescription decisions, and improve medication adherence.

Sector

Healthcare & Life Sciences

Verticals

Healthcare Analytics, Precision Medicine, Vertical SaaS

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting, Subscription SaaS, Government Contracts

AI Layer

Application

Keywords

Medication Therapy OptimizationMTOpharmacogenomicsPGxvalue-based careprecision medicineclinical pharmacist servicesshared savings modelhealthcare analyticsmedication risk managementPGx testingdrug-gene testingpolypharmacy management

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

DecisionRx Comparables

Compare DecisionRx with similar companies based on industry and business-model similarity.

DecisionRx comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
GalenusRx
84%
InformedDNA
80%
MedImpact Healthcare Systems
78%

DecisionRx Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
DebtJan 11, 2024

Key People

Founding team and executive leadership

Laura Breedlove

Chief Technology Officer

Executive Team

DecisionRx Investors

Notable investors and investment history

DecisionRx investors
InvestorRounds
Health Cloud CapitalSeries A
NWS HoldingsSeries A
The Carlyle GroupDebt
Claritas CapitalSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 20, 2026

    Monthly visitors grew 45% MoM, reaching 1.4K.

  • Feb 28, 2024

    Grew 33% QoQ, from 15 to 20 employees.

DecisionRx Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

DecisionRx Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about DecisionRx's valuation, stock price, and market status.

Firmographic Details

HeadquartersDover, Delaware
Employee Range16
Year Founded2022
Last FundingJan 11, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.